Men over 40 with faulty BRCA2 gene should be tested annually for prostate cancer
Michael Porter, University of Central Lancashire Scientists at The Institute of Cancer Research, London, are…
Browsing: Prostate Cancer
NCRI 2019: Men over 40 with BRCA2 gene fault ‘should get regular PSA screening’
Guidelines should change so that all men over the age of 40 with faults in…
NCRI 2019: High levels of two hormones in the blood raise prostate cancer risk
Men with higher levels of ‘free’ testosterone and a growth hormone in their blood are…
Does eating dairy foods increase your risk of prostate cancer?
Research Checks interrogate newly published studies and how they’re reported in the media. The analysis is…
Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in…
ESMO 2019: Men with prostate cancer can be spared radiotherapy after surgery
Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results…
ESMO 2019: Targeted therapy slows progression of advanced prostate cancer
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and…
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men
A drug used for breast and ovarian cancer is more effective than modern targeted hormone…
Trial finds high-dose radiation effective for men whose prostate cancer has spread
A randomised clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has…
Fathering children by assisted reproduction linked to increased risk of prostate cancer
Men who became fathers through assisted reproduction techniques seem to be at higher risk for…